| scholarly article | Q13442814 |
| P50 | author | Jonathan R Lindner | Q89706631 |
| Ian J. Sarembock | Q106705959 | ||
| P2093 | author name string | John M Sanders | |
| Aris Xie | |||
| Christopher Davis | |||
| Beat A Kaufmann | |||
| Patrick Aldred | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell adhesion | Q187640 |
| inflammation | Q101991 | ||
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 276-284 | |
| P577 | publication date | 2007-06-25 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. | |
| P478 | volume | 116 |
| Q35030851 | (64)Cu-labeled LyP-1-dendrimer for PET-CT imaging of atherosclerotic plaque |
| Q42616070 | 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis |
| Q56985984 | 2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis |
| Q36329223 | 68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors. |
| Q38005672 | A molecular imaging primer: modalities, imaging agents, and applications |
| Q30452349 | Acoustic tweezing cytometry for live-cell subcellular modulation of intracellular cytoskeleton contractility |
| Q37284563 | Advances in molecular imaging of atherosclerotic vascular disease |
| Q89231717 | An Introduction to Contrast-Enhanced Ultrasound for Nephrologists |
| Q38218986 | Antibody-based imaging strategies for cancer. |
| Q30364399 | Atherosclerosis and Nanotechnology: Diagnostic and Therapeutic Applications. |
| Q27021416 | Cardiovascular molecular imaging with contrast ultrasound: principles and applications. |
| Q37530107 | Cardiovascular molecular imaging: an overview |
| Q30479697 | Cardiovascular therapeutic uses of targeted ultrasound contrast agents |
| Q36351196 | Carotid inflammation is unaltered by exercise in hypercholesterolemic Swine |
| Q38742857 | Clinical imaging of vascular disease in chronic kidney disease |
| Q38983805 | Clinical significance of receptor shedding-platelet GPVI as an emerging diagnostic and therapeutic tool. |
| Q51152653 | Comparison of Magnetic Microbubbles and Dual-modified Microbubbles Targeted to P-selectin for Imaging of Acute Endothelial Inflammation in the Abdominal Aorta. |
| Q30433361 | Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis |
| Q34637387 | Construction and in vitro/in vivo targeting of PSMA-targeted nanoscale microbubbles in prostate cancer |
| Q37385650 | Contrast ultrasound molecular imaging of inflammation in cardiovascular disease |
| Q53420337 | Contrast-enhanced molecular ultrasound differentiates endoglin genotypes in mouse embryos. |
| Q57460608 | Contrast-enhanced ultrasound of the abdominal aorta - current status and future perspectives |
| Q39358630 | Contrast-enhanced ultrasound of the carotid system: a review of the current literature |
| Q30478163 | Contrast-enhanced ultrasound: The evolving applications |
| Q37657893 | Critical appraisal of targeted ultrasound contrast agents for molecular imaging in large arteries |
| Q37998112 | Current imaging modalities for atherosclerosis. |
| Q30435874 | Current status and prospects for microbubbles in ultrasound theranostics |
| Q57342839 | Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis |
| Q30356090 | Detection and characterization of murine colitis and carcinogenesis by molecularly targeted contrast-enhanced ultrasound |
| Q59471755 | Detection of Adhesion Molecules on Inflamed Macrophages at Early-Stage Using SERS Probe Gold Nanorods |
| Q30408017 | Detection of high-risk atherosclerotic plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa receptor on activated platelets |
| Q91784063 | Development of 68Ga-labelled ultrasound microbubbles for whole-body PET imaging |
| Q84329824 | Development of antibody-carrying microbubbles based on clinically available ultrasound contrast agent for targeted molecular imaging: a preliminary chemical study |
| Q35774087 | Diagnostic and prognostic utility of non-invasive imaging in diabetes management |
| Q30434058 | Dual frequency method for simultaneous translation and real-time imaging of ultrasound contrast agents within large blood vessels |
| Q37804385 | Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery |
| Q37771030 | Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review). |
| Q57144795 | Dynamics of targeted microbubble adhesion under pulsatile compared with steady flow |
| Q30461411 | Dysregulated selectin expression and monocyte recruitment during ischemia-related vascular remodeling in diabetes mellitus |
| Q42671952 | Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be inhibited by nitric oxide |
| Q37250743 | Echocardiography in translational research: of mice and men. |
| Q30420744 | Echogenic perfluorohexane-loaded macrophages adhere in vivo to activated vascular endothelium in mice, an explorative study |
| Q30477838 | Effect of acoustic power on in vivo molecular imaging with targeted microbubbles: implications for low-mechanical index real-time imaging. |
| Q37390765 | Emergence of targeted molecular imaging in atherosclerotic cardiovascular disease |
| Q30450437 | Emerging diagnostic and therapeutic molecular imaging applications in vascular disease |
| Q34898750 | Endothelial Nlrp3 inflammasome activation associated with lysosomal destabilization during coronary arteritis |
| Q49918938 | Endothelial vascular cell adhesion molecule 1 is a marker for high-risk carotid plaques and target for ultrasound molecular imaging |
| Q30384012 | Evaluation of Liver Ischemia-Reperfusion Injury in Rabbits Using a Nanoscale Ultrasound Contrast Agent Targeting ICAM-1. |
| Q37165155 | Form to function: current and future roles for atherosclerosis imaging in drug development |
| Q30473050 | Future applications of contrast ultrasound |
| Q34452433 | Human ferritin cages for imaging vascular macrophages |
| Q36339915 | Identification of neovascularization by contrast-enhanced ultrasound to detect unstable carotid stenosis |
| Q44927479 | Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents |
| Q33697215 | Imaging of atherosclerosis |
| Q30397684 | Improving the efficacy of therapeutic angiogenesis by UTMD-mediated Ang-1 gene delivery to the infarcted myocardium |
| Q30430111 | Improving ultrasound gene transfection efficiency by controlling ultrasound excitation of microbubbles |
| Q57477458 | In Vivo Molecular Imaging Using Low-Boiling-Point Phase-Change Contrast Agents: A Proof of Concept Study |
| Q30479461 | In Vivo Quantification of Vcam-1 Expression in Renal Ischemia Reperfusion Injury Using Non-Invasive Magnetic Resonance Molecular Imaging |
| Q91943358 | In vivo assessment of inflammation in carotid atherosclerosis by noninvasive photoacoustic imaging |
| Q27692593 | Inflammation and neovascularization intertwined in atherosclerosis: imaging of structural and molecular imaging targets |
| Q33709505 | Inflammation in atherosclerosis: from pathophysiology to practice |
| Q35094708 | Inflammation in cardiovascular tissue engineering: the challenge to a promise: a minireview |
| Q35586045 | Integrin-targeted imaging of inflammation in vascular remodeling |
| Q84791739 | Late-phase detection of recent myocardial ischaemia using ultrasound molecular imaging targeted to intercellular adhesion molecule-1 |
| Q30459779 | Leveraging the power of ultrasound for therapeutic design and optimization |
| Q37974931 | Liposome technology for cardiovascular disease treatment and diagnosis |
| Q38833728 | Low-Dose Molecular Ultrasound Imaging with E-Selectin-Targeted PBCA Microbubbles. |
| Q30425612 | Micro-ultrasound for preclinical imaging |
| Q36005391 | MicroRNA-181b regulates NF-κB-mediated vascular inflammation |
| Q37461932 | MicroRNAs: regulating a change of heart. |
| Q90346534 | Microbubble Formulations: Synthesis, Stability, Modeling and Biomedical Applications |
| Q38179566 | Microvascular platforms for the study of platelet-vessel wall interactions |
| Q35175784 | Minimally invasive, longitudinal monitoring of biomaterial-associated inflammation by fluorescence imaging. |
| Q38810997 | Molecular Acoustic Angiography: A New Technique for High-resolution Superharmonic Ultrasound Molecular Imaging |
| Q98945391 | Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe |
| Q27339951 | Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis |
| Q30460355 | Molecular Imaging of Vasa Vasorum Neovascularization via DEspR-targeted Contrast-enhanced Ultrasound Micro-imaging in Transgenic Atherosclerosis Rat Model |
| Q28070313 | Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models |
| Q30484224 | Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation |
| Q30442045 | Molecular imaging in cardiovascular disease: Which methods, which diseases? |
| Q37557366 | Molecular imaging in cardiovascular disease: targets and opportunities |
| Q36141999 | Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development |
| Q30461248 | Molecular imaging of cardiovascular disease using ultrasound |
| Q37511734 | Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography |
| Q36095916 | Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic |
| Q30457844 | Molecular imaging of disease with targeted contrast ultrasound imaging |
| Q30479243 | Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques? |
| Q36617730 | Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. |
| Q30446268 | Molecular imaging of inflammation in atherosclerosis |
| Q34498697 | Molecular imaging of plaque vulnerability |
| Q34260475 | Molecular imaging of plaques in coronary arteries with PET and SPECT. |
| Q30492960 | Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease |
| Q37466636 | Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties |
| Q37752025 | Molecular imaging with contrast enhanced ultrasound |
| Q83669147 | Molecular imaging with targeted contrast ultrasound |
| Q30474579 | Molecular imaging: current status and emerging strategies |
| Q37777365 | Molecular ultrasound imaging and its potential for paediatric radiology |
| Q30474725 | Molecular ultrasound imaging: current status and future directions |
| Q42370846 | Monitoring inflammation injuries in the progression of atherosclerosis with contrast enhanced ultrasound molecular imaging. |
| Q37569289 | Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions |
| Q30421973 | Nanobody-coupled microbubbles as novel molecular tracer |
| Q38034812 | Nanomedicine in cardiovascular therapy: recent advancements |
| Q38089761 | Nanotechnology in the diagnosis of atherosclerotic disease |
| Q30461404 | New approaches in small animal echocardiography: imaging the sounds of silence |
| Q30382612 | Nitric Oxide-Enhanced Molecular Imaging of Atheroma using Vascular Cellular Adhesion Molecule 1-Targeted Echogenic Immunoliposomes. |
| Q30410620 | Nitric oxide pretreatment enhances atheroma component highlighting in vivo with intercellular adhesion molecule-1-targeted echogenic liposomes |
| Q26824883 | Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque |
| Q26992143 | Non-invasive imaging of atherosclerosis |
| Q39201920 | Nonclinical safety biomarkers of drug-induced vascular injury: current status and blueprint for the future |
| Q30455730 | Noninvasive ultrasound molecular imaging of the effect of statins on endothelial inflammatory phenotype in early atherosclerosis |
| Q30279077 | Optical Verification of Microbubble Response to Acoustic Radiation Force in Large Vessels With In Vivo Results |
| Q39411412 | Optimization of ultrasound contrast agents with computational models to improve selection of ligands and binding strength |
| Q27330273 | Oscillatory Dynamics and In Vivo Photoacoustic Imaging Performance of Plasmonic Nanoparticle-Coated Microbubbles |
| Q39911952 | Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging |
| Q37438144 | Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview |
| Q84857501 | Precocious virulent coronary atherosclerosis in the very young |
| Q37794017 | Principles and basic concepts of molecular imaging |
| Q37540095 | Proinflammatory endothelial activation detected by molecular imaging in obese nonhuman primates coincides with onset of insulin resistance and progressively increases with duration of insulin resistance |
| Q35629916 | Quantification and monitoring of inflammation in murine inflammatory bowel disease with targeted contrast-enhanced US. |
| Q30442545 | Quantitative photoacoustic imaging of nanoparticles in cells and tissues |
| Q50903873 | Quantitative ultrasound molecular imaging. |
| Q30473856 | Radiation-induced tumor neoantigens: imaging and therapeutic implications. |
| Q30417617 | Real-time targeted molecular imaging using singular value spectra properties to isolate the adherent microbubble signal |
| Q30430526 | Real-time technique for improving molecular imaging and guiding drug delivery in large blood vessels: in vitro and ex vivo results |
| Q30436709 | Recent advances in molecular, multimodal and theranostic ultrasound imaging |
| Q38233595 | Recent advances in visualizing vulnerable plaque: focus on noninvasive molecular imaging. |
| Q37076299 | Role of echocardiography in the diagnosis and management of asymptomatic severe aortic stenosis |
| Q92396778 | Seeing the Invisible-Ultrasound Molecular Imaging |
| Q53132563 | Sentinel Lymph Node Characterization with a Dual-Targeted Molecular Ultrasound Contrast Agent. |
| Q39341721 | Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases |
| Q37841416 | Standardization of models and methods used to assess nanoparticles in cardiovascular applications |
| Q38995734 | Status and trends in the development of clinical diagnostic agents. |
| Q37787083 | Target: ligand interactions of the vascular endothelium. Implications for molecular imaging in inflammation |
| Q38056019 | Targeted molecular imaging of vascular inflammation in cardiovascular disease using nano- and micro-sized agents |
| Q30472688 | Targeted renal therapies through microbubbles and ultrasound☆ |
| Q38364441 | Targeted ultrasound contrast agents for ultrasound molecular imaging and therapy |
| Q89016930 | Targeting and Modulation of Liver Myeloid Immune Cells by Hard-Shell Microbubbles |
| Q47234214 | Targeting of microbubbles: contrast agents for ultrasound molecular imaging. |
| Q49079310 | Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques |
| Q45339905 | The effect of binding on the subharmonic emissions from individual lipid-encapsulated microbubbles at transmit frequencies of 11 and 25 MHz. |
| Q38056484 | The role of imaging in acute aortic syndromes |
| Q30464013 | The role of poly(ethylene glycol) brush architecture in complement activation on targeted microbubble surfaces |
| Q30275871 | Ultra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See? |
| Q50881427 | Ultrasound Imaging Based on Molecular Targeting for Quantitative Evaluation of Hepatic Ischemia-Reperfusion Injury. |
| Q88083584 | Ultrasound Molecular Imaging of Atherosclerosis Using Small-Peptide Targeting Ligands Against Endothelial Markers of Inflammation and Oxidative Stress |
| Q54999116 | Ultrasound Molecular Imaging of Atherosclerosis for Early Diagnosis and Therapeutic Evaluation through Leucocyte-like Multiple Targeted Microbubbles. |
| Q30252540 | Ultrasound Molecular Imaging of Inflammation in Mouse Abdominal Aorta |
| Q47140332 | Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy |
| Q26853667 | Ultrasound contrast materials in cardiovascular medicine: from perfusion assessment to molecular imaging |
| Q28087550 | Ultrasound imaging for risk assessment in atherosclerosis |
| Q37424337 | Ultrasound molecular imaging |
| Q37506868 | Ultrasound molecular imaging of atherosclerosis |
| Q30434285 | Ultrasound molecular imaging of cardiovascular disease |
| Q30445036 | Ultrasound molecular imaging with targeted microbubble contrast agents |
| Q89706634 | Ultrasound molecular imaging: insights into cardiovascular pathology |
| Q30303105 | Ultrasound-based measurement of molecular marker concentration in large blood vessels: a feasibility study |
| Q39251732 | VCAM-1-targeting gold nanoshell probe for photoacoustic imaging of atherosclerotic plaque in mice. |
| Q92944443 | Validation of Normalized Singular Spectrum Area as a Classifier for Molecularly Targeted Microbubble Adherence |
| Q38957484 | Vascular targeting of nanoparticles for molecular imaging of diseased endothelium |
| Q39361987 | Versatile synthetic strategies for PBCA-based hybrid fluorescent microbubbles and their potential theranostic applications to cell labelling and imaging |
| Q41510549 | Visualization of tumor angiogenesis using MR imaging contrast agent Gd-DTPA-anti-VEGF receptor 2 antibody conjugate in a mouse tumor model |
| Q38187881 | Visualizing the atherosclerotic plaque: a chemical perspective |
| Q38065810 | Vulnerable atherosclerotic plaque: from the basic research laboratory to the clinic |
| Q53268266 | [Imaging of molecular structures of breasts with new sonography techniques]. |
| Q86386609 | [Molecular ultrasound imaging: Clinical applications] |
| Q30425448 | scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis |
Search more.